News

Filter

Current filters:

Respiratory and Pulmonary

176 to 185 of 97230 results

Labeling update of Lundbeck and Otsuka’s Abilify Maintena approved by FDA

08-12-2014

The US Food and Drug Administration approved the labeling update of Abilify Maintena (aripiprazole) for…

Abilify MaintenaLundbeckNeurologicalOtsuka PharmaceuticalPharmaceuticalRegulationUSA

ASH 2014: Amgen and Onyx report primary endpoint met in Kyprolis combination trial

ASH 2014: Amgen and Onyx report primary endpoint met in Kyprolis combination trial

08-12-2014

USA-based Amgen and its subsidiary Onyx Pharmaceuticals announced the results of the Phase III ASPIRE…

AmgenBiotechnologyDexamethasoneKyprolisOncologyOnyx PharmaceuticalsResearchRevlimid

Sources say Merck to buy Cubist in $7 billion deal

Sources say Merck to buy Cubist in $7 billion deal

08-12-2014

Sources close to the matter say pharma giant Merck & Co has entered negotiations with Cubist Pharmaceuticals…

CubicinCubist PharmaceuticalsMerck & CoMergers & AcquisitionsPharmaceuticalUSA

ASH 2014: Merck reports overall response rate of 66% for its Keytruda in Hodgkin's lymphoma

ASH 2014: Merck reports overall response rate of 66% for its Keytruda in Hodgkin's lymphoma

08-12-2014

Keytruda (pembrolizumab), manufactured by pharma giant Merck & Co, has achieved an overall response rate…

KeytrudaMerck & CoOncologyPharmaceuticalResearchUSA

ASH 2014: AbbVie's venetoclax shows promise in Phase II trial

ASH 2014: AbbVie's venetoclax shows promise in Phase II trial

08-12-2014

US drugmaker AbbVie presented data at the American Society of Hematology’s annual meeting, demonstrating…

AbbVieOncologyPharmaceuticalResearchUSA

Positive new Ph III data for Novo Nordisk’s NovoEight in hemophilia A

08-12-2014

Danish diabetes major Novo Nordisk yesterday presented a new analysis of Phase III data demonstrating…

HematologyNovo NordiskNovoEightPharmaceuticalResearch

AstraZeneca wins in US Nexium pay-for-delay litigation

AstraZeneca wins in US Nexium pay-for-delay litigation

07-12-2014

Anglo-Swedish pharma major AstraZeneca revealed on Friday that a jury in the US District Court for the…

AstraZenecaGastro-intestinalsGenericsLegalNexiumPatentsRanbaxyUSA

Orexo presents new Ph III data for Zubsolv

07-12-2014

The US subsidiary of Swedish drug developer Orexo says that, in the ISTART Phase III study, Zubsolv (buprenorphine…

NeurologicalOrexoPharmaceuticalResearchSuboxoneZubsolv

Bayer files for European approval of hemophilia A drug BAY 81-8973

06-12-2014

German pharma major Bayer has filed an application for marketing authorization to the European Medicines…

BAY 81-8973BayerEuropeHematologyPharmaceuticalRegulation

176 to 185 of 97230 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top